Possible Real-Time Adaptive Approach to Breast MRI Suggests ‘New Era’ of AI-Directed MRI

New research suggests the potential of employing artificial intelligence (AI) in real-time to help determine whether to proceed with a full breast magnetic resonance imaging (MRI) examination or opt for an abbreviated breast MRI (AB-MRI). For the retrospective study, recently published in Radiology, researchers performed a simulation study with a cohort of 863 women to … Read more

What a New PSMA PET/CT Study Reveals About Local PCa Treatment and High-Risk Recurrence

For the majority of patients at high-risk for biochemical recurrence of prostate cancer (PCa), new prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) research reaffirms a lack of sustained efficacy for monotherapy treatment with local radiation therapy or radical prostatectomy. For the retrospective study, recently published in BJUI Compass, researchers reviewed PSMA PET/CT data … Read more

Anthracycline-Sparing Strategies Help Refine HER2+ Breast Cancer Management

The treatment paradigm for HER2-positive breast cancer continues to evolve with a growing emphasis on anthracycline-sparing approaches and the refinement of initial strategies in both the early-stage and metastatic settings, according to Paolo Tarantino, MD. “I do feel the future will have more and more anthracycline-sparing [regimens], acknowledging that there are few selected populations of … Read more

Breast MRI Quantification of Intra-Tumoral Heterogeneity May Help Predict Response to Neoadjuvant Chemotherapy

A nomogram that combines breast MRI-derived intra-tumoral heterogeneity (ITH) quantification with clinicopathologic factors may offer significant prognostic benefit in assessing neoadjuvant chemotherapy response in patients with breast cancer. In a new multicenter retrospective study, recently published in Radiology, researchers trained and evaluated the capability of the nomogram to predict pathologic complete response (pCR) in a … Read more

Study with CT Data Suggests Women with PE Have More Than Triple the One-Year Mortality Rate than Men

New research suggests that women have a significantly higher risk of death within one year of pulmonary embolism (PE) detection than men. For the retrospective study, recently published in Clinical Imaging, researchers reviewed data from 33,628 women (mean age of 55) who had computed tomography (CT) pulmonary angiography or ventilation/perfusion scintigraphy over a seven-year period … Read more

The Long-Term Impact of COVID-19 on Oncology Care: A Five-Year Retrospective

Five years after the onset of the COVID-19 pandemic, the oncology field continues to grapple with its repercussions. From fundamental shifts in patient management, including the introduction of telemedicine, to trial disruptions and workforce challenges, the pandemic has reshaped every aspect of oncology care. Although some of these adaptations offer unique benefits, others require strategic … Read more

City of Hope-Led Study Demystifies Tumor Formation’s Two-Step Process — A Foundational Understanding Needed to Prevent Cancer

Researchers at City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the US with its National Medical Center named top 5 in the nation for cancer by US News & World Report, have found that cell mutations are necessary but not always sufficient for tumors to form. Instead, … Read more

Oncologists Call for Equity and Female Representation in Research During Women’s History Month

This Women’s History Month, OncLive is spotlighting transformative and groundbreaking female-led research, the unique challenges women face as patients and practitioners, and the women advancing oncology practice and care each and every day. On International Women’s Day, we were joined by Shruti Patel, MD, a clinical assistant professor of medicine-oncology at Stanford Medicine in California, … Read more

Patient Guidance and Care Drives McCann’s Passion as a Woman in Oncology

Although her drive to become a scientist grew in a lab, the patient-centered aspect of medical oncology—specifically, breast cancer care—sparked the drive for Kelly E. McCann, MD, to enter the oncology field. “When I was doing [PhD] training, I realized that I wanted to go more into the patient care route, because in order to … Read more